Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (8): 808-809.DOI: 10.3969/j.issn.1673-8640.2015.08.008
Previous Articles Next Articles
Received:2014-12-03
Online:2015-08-30
Published:2015-08-28
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2015.08.008
| 组别 | 例数 | BNP(pg/mL) |
|---|---|---|
| 正常对照组 | 30 | 19.9±17.5 |
| 急性心衰组 | 50 | 222.4±101.7* |
| killipⅠ级 | 18 | 115.15(46.4~233.4) |
| killipⅡ级 | 24 | 222.8(112.4~369.9)# |
| killipⅢ级 | 8 | 442.2(332.0~682.0)#△ |
| 组别 | 例数 | BNP(pg/mL) |
|---|---|---|
| 正常对照组 | 30 | 19.9±17.5 |
| 急性心衰组 | 50 | 222.4±101.7* |
| killipⅠ级 | 18 | 115.15(46.4~233.4) |
| killipⅡ级 | 24 | 222.8(112.4~369.9)# |
| killipⅢ级 | 8 | 442.2(332.0~682.0)#△ |
| [1] | 马娟,张鸿青,田青.B型利钠肽在心力衰竭治疗中的应用[J].心血管病学进展,2009,30(Z1):20-22. |
| [2] | 中华医学会心血管学分会,中华心血管病杂志编辑委员会.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. |
| [3] | 葛均波,徐永健.内科学[M].8版.北京:人民卫生出版社,2014:174. |
| [4] | 刘人伟. 检验与临床[M].2版.北京:人民卫生出版社,2009:608. |
| [5] | 应晓. B型钠尿肽在心力衰竭中的临床应用价值[J].检验医学,2010,25(4):317-318. |
| [6] | 原永明,王慧,尹良平,等.慢性心力衰竭患者BNP、hs-CRP水平检测的临床意义[J].检验医学,2015,30(6):591-592. |
| [7] | 贺岩,李富荣,杜宗孝,等.血清BNP、hs-CRP、cTnI及UA联合检测对心力衰竭的临床价值[J].检验医学,2012,27(8):647-650. |
| [8] | 张汉园,陈金梅.血清3项指标在急性心肌梗死诊断及预后中的关系[J].检验医学与临床,2011, 8(22):2737-2738. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
